SRNE — Sorrento Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.17m
- $68.79m
- $62.84m
Brief: Sorrento Says Oral SARS-CoV-2 Main Protease Inhibitor, STI-1558, Strongly Neutralizes Omicron
Brief: Sorrento Therapeutics Receives Purchase Order For 10 Million Covistix Tests
Brief: Sorrento Announces That Sorrento Mexico Has Sold Out Of One Million Covistix Tests Last Week In Mexico
Brief: Brazilian Health Regulatory Agency (Anvisa) Authorizes Sorrento Phase 2 Trial Of Covi-Msc In Long-Hauler Covid-19 Patients
Brief: Sorrento Therapeutics Mexico Wins Tender To Sell COVISTIX Tests To Mexico City Government
Brief: Sorrento Therapeutics Inc Says Henry Ji, Co's Chairman Of Board, President And CEO, To Serve As Co’S Interim Chief Financial Officer
Brief: Sorrento Therapeutics Announces The Unexpected Death Of Its Chief Financial Officer
Brief: Sorrento Announces Covistix Covid-19 Rapid Antigen Detection Test Detects Omicron Variant
Brief: Sorrento Therapeutics Executes Second Contract For Sale Of 10 Mln Covistix Tests For Mexico
Brief: Sorrento Therapeutics - Entered Into Amendment No. 1 To Certain Amended And Restated Sales Agreement, Dated Dec 3, 2021
Brief: Sorrento Therapeutics Announces FDA Clearance Of Its Ind Application Of Next Generation Ohsv Oncolytic Virus STI-1386
Brief: Scilex C.L.E.A.R. Program Trial Has Met Primary Efficacy And Key Secondary Efficacy Endpoints With Highly Statistical Significance
Brief: Sorrento Receives Orders Of Covistix For Commercial Launch In Brazil
Brief: Scilex Holding Company, A Sorrento Therapeutics Inc Subsidiary, And Vickers Vantage Corp I (“Spac”) Enter Into Letter Of Intent For Proposed Business Combination
Brief: Sorrento Announces Publication Of A Series Of Novel Sars-Cov-2 Main Protease (MPRO) Inhibitors For Potential Treatment Of COVID-19 Patients Infected With SARS-COV-2 Variants Of Concern, Including Omicron
Brief: Sorrento Therapeutics Inc Amended And Restated Sales Agreement Dated April 27, 2020
Brief: Sorrento Therapeutics Mexico Executes Contract For Sale Of 5 Million COVI-STIX Tests For Mexico Market
Brief: Sorrento Announces Publication Of Pivotal Trial Results Of Non-Small Cell Lung Cancer Treatment
Brief: Sorrento Awarded California Competes Tax Credit